Patents by Inventor Mark Chandrakant Lakshmanan

Mark Chandrakant Lakshmanan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC USES OF DULAGLUTIDE
    Publication number: 20200171129
    Abstract: The present invention relates to methods of using dulaglutide for the treatment of chronic kidney disease in patients having moderate to late stage chronic kidney disease.
    Type: Application
    Filed: May 24, 2018
    Publication date: June 4, 2020
    Inventors: Fady Talaat Botros, Mark Chandrakant Lakshmanan, Katherine Rose Tuttle, Alan George Zimmerman
  • Compositions And Methods For Treating Dyslipidemia
    Publication number: 20090137632
    Abstract: The present invention provides a method for treating dyslipidemia in a mammal, comprising administering to a mammal in need thereof, an effective amount of a compound of Formula (I): or a pharmaceutically acceptable salt or solvate thereof and at least one statin.
    Type: Application
    Filed: February 2, 2006
    Publication date: May 28, 2009
    Inventors: M. Johnston Erwin, Mohamed Wa'el Ahned Hashad, Mark Chandrakant Lakshmanan, Iris Rajman
  • Methods for lowering platelet counts
    Patent number: 6103740
    Abstract: A method of safely lowering platelet count in a human which comprises the administration to a human in need thereof of an effective amount of a compound of formula I ##STR1## wherein R.sup.1 and R.sup.3 are, independently, --H, --CH.sub.3, --CO(C.sub.1 -C.sub.6 alkyl), or --COAr, where Ar is optionally substituted phenyl;R.sup.2 is selected from the group consisting of pyrrolidine, piperidine, and hexamethyleneimino; ora pharmaceutically acceptable salt or solvate thereof.
    Type: Grant
    Filed: August 4, 1998
    Date of Patent: August 15, 2000
    Assignee: Eli Lilly and Company
    Inventor: Mark Chandrakant Lakshmanan
  • Methods for preventing headaches
    Patent number: 6008232
    Abstract: A method of preventing headache in a human is disclosed which comprises the administration to a human in need thereof of an effective amount of a compound of formula I ##STR1## wherein R.sup.1 and R.sup.3 are, independently, --H, --CH.sub.3, --CO(C.sub.1 -C.sub.6 alkyl), or --COAr, where Ar is optionally substituted phenyl;R.sup.2 is selected from the group consisting of pyrrolidine, piperidine, and hexamethyleneimino; ora pharmaceutically acceptable salt or solvate thereof.
    Type: Grant
    Filed: August 4, 1998
    Date of Patent: December 28, 1999
    Assignee: Eli Lilly and Company
    Inventor: Mark Chandrakant Lakshmanan